144 related articles for article (PubMed ID: 24407024)
1. Mammalian Dopa decarboxylase: structure, catalytic activity and inhibition.
Bertoldi M
Arch Biochem Biophys; 2014 Mar; 546():1-7. PubMed ID: 24407024
[TBL] [Abstract][Full Text] [Related]
2. Reaction of dopa decarboxylase with L-aromatic amino acids under aerobic and anaerobic conditions.
Bertoldi M; Borri Voltattorni C
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):533-8. PubMed ID: 11085948
[TBL] [Abstract][Full Text] [Related]
3. Reaction and substrate specificity of recombinant pig kidney Dopa decarboxylase under aerobic and anaerobic conditions.
Bertoldi M; Borri Voltattorni C
Biochim Biophys Acta; 2003 Apr; 1647(1-2):42-7. PubMed ID: 12686106
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of oxidative deamination catalyzed by DOPA decarboxylase.
Bertoldi M; Cellini B; Montioli R; Borri Voltattorni C
Biochemistry; 2008 Jul; 47(27):7187-95. PubMed ID: 18547057
[TBL] [Abstract][Full Text] [Related]
5. Multiple roles of the active site lysine of Dopa decarboxylase.
Bertoldi M; Voltattorni CB
Arch Biochem Biophys; 2009 Aug; 488(2):130-9. PubMed ID: 19580779
[TBL] [Abstract][Full Text] [Related]
6. Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase.
Burkhard P; Dominici P; Borri-Voltattorni C; Jansonius JN; Malashkevich VN
Nat Struct Biol; 2001 Nov; 8(11):963-7. PubMed ID: 11685243
[TBL] [Abstract][Full Text] [Related]
7. Reaction specificity of native and nicked 3,4-dihydroxyphenylalanine decarboxylase.
Bertoldi M; Frigeri P; Paci M; Voltattorni CB
J Biol Chem; 1999 Feb; 274(9):5514-21. PubMed ID: 10026165
[TBL] [Abstract][Full Text] [Related]
8. Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase. Effects on catalytic properties.
Bertoldi M; Castellani S; Bori Voltattorni C
Eur J Biochem; 2001 May; 268(10):2975-81. PubMed ID: 11358515
[TBL] [Abstract][Full Text] [Related]
9. Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine).
Bertoldi M; Voltattorni CB
Protein Sci; 2001 Jun; 10(6):1178-86. PubMed ID: 11369856
[TBL] [Abstract][Full Text] [Related]
10. Structural perspective on the direct inhibition mechanism of EGCG on mammalian histidine decarboxylase and DOPA decarboxylase.
Ruiz-Pérez MV; Pino-Ángeles A; Medina MA; Sánchez-Jiménez F; Moya-García AA
J Chem Inf Model; 2012 Jan; 52(1):113-9. PubMed ID: 22107329
[TBL] [Abstract][Full Text] [Related]
11. Reaction of dopa decarboxylase with alpha-methyldopa leads to an oxidative deamination producing 3,4-dihydroxyphenylacetone, an active site directed affinity label.
Bertoldi M; Dominici P; Moore PS; Maras B; Voltattorni CB
Biochemistry; 1998 May; 37(18):6552-61. PubMed ID: 9572873
[TBL] [Abstract][Full Text] [Related]
12. Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase.
Borri Voltattorni C; Bertoldi M; Bianconi S; Deng WP; Wong K; Kim I; Herbert B; Kirk KL
Biochem Biophys Res Commun; 2002 Jul; 295(1):107-11. PubMed ID: 12083775
[TBL] [Abstract][Full Text] [Related]
13. S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine.
Montioli R; Oppici E; Cellini B; Roncador A; Dindo M; Voltattorni CB
Hum Mol Genet; 2013 Apr; 22(8):1615-24. PubMed ID: 23321058
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency.
Montioli R; Cellini B; Borri Voltattorni C
J Inherit Metab Dis; 2011 Dec; 34(6):1213-24. PubMed ID: 21541720
[TBL] [Abstract][Full Text] [Related]
15. A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase.
Bertoldi M; Cellini B; Maras B; Voltattorni CB
FEBS Lett; 2005 Sep; 579(23):5175-80. PubMed ID: 16150447
[TBL] [Abstract][Full Text] [Related]
16. Theoretical studies on the pyridoxal-5'-phosphate dependent enzyme dopa decarboxylase: effect of thr 246 residue on the co-factor-enzyme binding and reaction mechanism.
Chakrabarty K; Gupta SN; Das GK; Roy S
Indian J Biochem Biophys; 2012 Jun; 49(3):155-64. PubMed ID: 22803330
[TBL] [Abstract][Full Text] [Related]
17. Kinetic isotope effects of L-Dopa decarboxylase.
Lin YL; Gao J
J Am Chem Soc; 2011 Mar; 133(12):4398-403. PubMed ID: 21366322
[TBL] [Abstract][Full Text] [Related]
18. Oxygen reactivity with pyridoxal 5'-phosphate enzymes: biochemical implications and functional relevance.
Bisello G; Longo C; Rossignoli G; Phillips RS; Bertoldi M
Amino Acids; 2020 Aug; 52(8):1089-1105. PubMed ID: 32844248
[TBL] [Abstract][Full Text] [Related]
19. Novel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra Roxb.
Ren J; Zhang Y; Jin H; Yu J; Zhou Y; Wu F; Zhang W
ACS Chem Biol; 2014 Apr; 9(4):897-903. PubMed ID: 24471650
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristic and physiological role of DOPA-decarboxylase.
Guenter J; Lenartowski R
Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1424-1440. PubMed ID: 28100850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
